Publications

Featured publications

Traversing the bench to bedside journey for iNKT cell therapies

August 7, 2024

O’Neal J, Mavers M, Jayasinghe RG, DiPersio JF. Traversing the bench to bedside journey for iNKT cell therapies. Front Immunol. 2024 Aug 7;15:1436968. doi: 10.3389/fimmu.2024.1436968. PMID: 39170618; PMCID: PMC11335525.

Recruitment and Retention of Hematopoietic Cell Transplantation and Cellular Therapy Physicians: A Report from the ASTCT Talent Acquisition Task Force

June 1, 2024

Sharma A, Czechowicz A, Mavers M, Chao N, DiPersio J, Reddy P, Perales MA, Smith M. Recruitment and Retention of Hematopoietic Cell Transplantation and Cellular Therapy Physicians: A Report from the ASTCT Talent Acquisition Task Force. Transplant Cell Ther. 2024 Jun;30(6):559-564. doi: 10.1016/j.jtct.2024.04.005. Epub 2024 Apr 11. PMID: 38608806; PMCID: PMC11216222.

Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with FOXP3 mutations

December 20, 2023

Borna Š, Lee E, Nideffer J, Ramachandran A, Wang B, Baker J, Mavers M, Lakshmanan U, Narula M, Garrett AK, Schulze J, Olek S, Marois L, Gernez Y, Bhatia M, Chong HJ, Walter J, Kitcharoensakkul M, Lang A, Cooper MA, Bertaina A, Roncarolo MG, Meffre E, Bacchetta R. Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with FOXP3 mutations. Sci Transl Med. 2023 Dec 20;15(727):eadg6822. doi: 10.1126/scitranslmed.adg6822. Epub 2023 Dec 20. PMID: 38117899; PMCID: PMC11070150.

Inhibiting post-translational methylation to prevent GVHD

November 1, 2023

Mavers M. Inhibiting post-translational methylation to prevent GVHD. Mol Ther. 2023 Nov 1;31(11):3115-3116. doi: 10.1016/j.ymthe.2023.10.009. Epub 2023 Oct 20. PMID: 37865095; PMCID: PMC10638046.

Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effects

September 9, 2021

Maas-Bauer K, Lohmeyer JK, Hirai T, Ramos TL, Fazal FM, Litzenburger UM, Yost KE, Ribado JV, Kambham N, Wenokur AS, Lin PY, Alvarez M, Mavers M, Baker J, Bhatt AS, Chang HY, Simonetta F, Negrin RS. Invariant natural killer T-cell subsets have diverse graft-versus-host-disease-preventing and antitumor effects. Blood. 2021 Sep 9;138(10):858-870. doi: 10.1182/blood.2021010887. PMID: 34036317; PMCID: PMC8432044.

Recent publications

• Letermovir as cytomegalovirus prophylaxis in children undergoing allogeneic hematopoietic cell transplantation
  August 1, 2024
  Letermovir as cytomegalovirus prophylaxis in children undergoing allogeneic hematopoietic cell transplantationPfeiffer, T., Lockowitz, C. R., Shenoy, S., Mavers, M., Hayashi, R., Bednarski, J. & Green, A., Aug 2024, In: Bone Marrow Transplantation. 59, 8, p. 1193-1195 3 p.Research output: Contribution to journal › Letter › peer-review
• Recruitment and Retention of Hematopoietic Cell Transplantation and Cellular Therapy Physicians: A Report from the ASTCT Talent Acquisition Task Force
  June 1, 2024
  Recruitment and Retention of Hematopoietic Cell Transplantation and Cellular Therapy Physicians: A Report from the ASTCT Talent Acquisition Task ForceSharma, A., Czechowicz, A., Mavers, M., Chao, N., DiPersio, J., Reddy, P., Perales, M. A. & Smith, M., Jun 2024, In: Transplantation and Cellular Therapy. 30, 6, p. 559-564 6 p.Research output: Contribution to journal › Article › peer-review
• Inhibiting post-translational methylation to prevent GVHD
  November 1, 2023
  Inhibiting post-translational methylation to prevent GVHDMavers, M., Nov 1 2023, In: Molecular Therapy. 31, 11, p. 3115-3116 2 p.Research output: Contribution to journal › Comment/debate
• Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with FOXP3 mutations
  January 1, 2023
  Identification of unstable regulatory and autoreactive effector T cells that are expanded in patients with FOXP3 mutationsBorna, Š., Lee, E., Nideffer, J., Ramachandran, A., Wang, B., Baker, J., Mavers, M., Lakshmanan, U., Narula, M., Garrett, A. K. H., Schulze, J., Olek, S., Marois, L., Gernez, Y., Bhatia, M., Chong, H. J., Walter, J., Kitcharoensakkul, M., Lang, A. & Cooper, M. A. & 4 others, Bertaina, A., Roncarolo, M. G., Meffre, E. & Bacchetta, R., 2023, In: Science translational medicine. 15, 727, eadg6822.Research output: Contribution to journal › Article › peer-review
• Invariant natural killer T-cell subsets have diverse graft-versus-host-disease–preventing and antitumor effects
  September 9, 2021
  Invariant natural killer T-cell subsets have diverse graft-versus-host-disease–preventing and antitumor effectsMaas-Bauer, K., Lohmeyer, J. K., Hirai, T., Ramos, T. L., Fazal, F. M., Litzenburger, U. M., Yost, K. E., Ribado, J. V., Kambham, N., Wenokur, A. S., Lin, P. Y., Alvarez, M., Mavers, M., Baker, J., Bhatt, A. S., Chang, H. Y., Simonetta, F. & Negrin, R. S., Sep 9 2021, In: Blood. 138, 10, p. 858-870 13 p.Research output: Contribution to journal › Article › peer-review
• Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHD
  June 8, 2021
  Activation of natural killer T cells enhances the function of regulatory T-cell therapy in suppressing murine GVHDHirai, T., Lin, P. Y., Simonetta, F., Maas-Bauer, K., Turkoz, M., Mavers, M., Baker, J. & Negrin, R. S., Jun 8 2021, In: Blood Advances. 5, 11, p. 2528-2538 11 p.Research output: Contribution to journal › Article › peer-review
• Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation tolerance
  April 15, 2021
  Selective expansion of regulatory T cells using an orthogonal IL-2/IL-2 receptor system facilitates transplantation toleranceHirai, T., Ramos, T. L., Lin, P. Y., Simonetta, F., Su, L. L., Picton, L. K., Baker, J., Lin, J. X., Li, P., Seo, K., Lohmeyer, J. K., Wagers, S. B., Mavers, M., Leonard, W. J., Blazar, B. R., Garcia, K. C. & Negrin, R. S., Apr 15 2021, In: Journal of Clinical Investigation. 131, 8, e139991.Research output: Contribution to journal › Article › peer-review
• Brentuximab vedotin as consolidation therapy after autologous stem cell transplantation in children and adolescents (<18 y) with early relapse hodgkin lymphoma
  March 1, 2021
  Brentuximab vedotin as consolidation therapy after autologous stem cell transplantation in children and adolescents (
• Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host Disease
  February 1, 2021
  Broad-Spectrum Antibiotics and Risk of Graft-versus-Host Disease in Pediatric Patients Undergoing Transplantation for Acute Leukemia: Association of Carbapenem Use with the Risk of Acute Graft-versus-Host DiseaseElgarten, C. W., Li, Y., Getz, K. D., Hemmer, M., Huang, Y. S. V., Hall, M., Wang, T., Kitko, C. L., Jagasia, M. H., Nishihori, T., Murthy, H. S., Hashem, H., Cairo, M. S., Sharma, A., Hashmi, S. K., Askar, M., Beitinjaneh, A., Kelly, M. S., Auletta, J. J. & Badawy, S. M. & 6 others, Mavers, M., Aplenc, R., MacMillan, M. L., Spellman, S. R., Arora, M. & Fisher, B. T., Feb 2021, In: […]
• Activation of the DR3-TL1A axis in donor mice leads to regulatory T cell expansion and activation with reduction in graft-versus-host disease
  January 1, 2019
  Activation of the DR3-TL1A axis in donor mice leads to regulatory T cell expansion and activation with reduction in graft-versus-host diseaseMavers, M., Simonetta, F., Nishikii, H., Ribado, J. V., Maas-Bauer, K., Alvarez, M., Hirai, T., Turkoz, M., Baker, J. & Negrin, R. S., 2019, In: Frontiers in immunology. 10, JULY, 1624.Research output: Contribution to journal › Article › peer-review